- Home
- ESCA vs ACIU Comparison
ESCA vs ACIU Comparison
Compare ESCA & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESCA | ACIU |
|---|---|---|
| Founded | 1922 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.4M | 213.3M |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ESCA | ACIU |
|---|---|---|
| Price | $17.62 | $3.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 45.1K | ★ 244.5K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.47% | N/A |
| EPS Growth | ★ 6.45 | N/A |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $180,541,000.00 | N/A |
| Revenue This Year | $4.15 | $635.38 |
| Revenue Next Year | N/A | $232.58 |
| P/E Ratio | $17.77 | ★ N/A |
| Revenue Growth | ★ 2.71 | N/A |
| 52 Week Low | $11.41 | $1.45 |
| 52 Week High | $18.61 | $4.00 |
Technical Indicators
Market Signals| Indicator | ESCA | ACIU |
|---|---|---|
| Relative Strength Index (RSI) | 57.19 | 61.19 |
| Support Level | $16.77 | $3.18 |
| Resistance Level | $18.53 | $3.43 |
| Average True Range (ATR) | 0.76 | 0.20 |
| MACD | -0.12 | 0.07 |
| Stochastic Oscillator | 51.63 | 81.91 |
Price Performance
Historical ComparisonAbout ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are the United States, Canada, Australia, and Other regions.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.